Abstract 7002: Discovery of DXTX-1464: A first-in-class, highly potent and selective degrader of CCNE1/CCNE2 and CDK2 for cancer therapy
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Tim Dwight, Andrew Allen, Vivian Guo, Justin Radatti, Stephane Corbel, Stephane Billotte, Paul Greenspan, MIke Wood, Humphrey Gardner, Bryce Kenneth Allen
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409633107